MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Technology Scientific & Technical Instruments

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > mir's omnicron test ? more difficult than first presented ?

<< Previous

Bullboard Posts

Next >>

Comment by conservative2on Jan 21, 2022 8:16am

143 Views

Post# 34341343

RE:mir's omnicron test ? more difficult than first presented ?

HMMMM. I do not see anything about precise saliva colletion process. I simply see that they are looking for a company in the USA to partner with. All good from where I am sitting.

keep safe.

cheers

conservative2

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks